Zobrazeno 1 - 10
of 223
pro vyhledávání: '"Chollet Philippe"'
Autor:
Passildas Jahanmohan Judith, Bernadach Maureen, Pouget Mélanie, Kwiatkowski Fabrice, Vanpraagh‐Doreau Isabelle, Dubray‐Longeras Pascale, Abrial Catherine, Nabholtz Jean‐Marc, Curé Hervé, Delecroix Valérie, Chollet Philippe, Mouret‐Reynier Marie‐Ange
Publikováno v:
Health Science Reports, Vol 7, Iss 9, Pp n/a-n/a (2024)
Abstract Background In this study, we investigated whether the association of curcumin and docetaxel among advanced and metastatic breast cancer patients in first or second‐line treatment potentiated the objective response rate. Patients/Methods A
Externí odkaz:
https://doaj.org/article/b2368d474d72492f9ad93e33ec66f452
Autor:
Kwiatkowski Fabrice, Planchat Eloïse, Gadéa Emilie, Gimbergues Pierre, Abrial Catherine, Lapirot Olivier, Thérondel Sophie, Thivat Emilie, Mouret-Reynier Marie A, Chollet Philippe, Durando Xavier
Publikováno v:
BMC Cancer, Vol 10, Iss 1, p 648 (2010)
Abstract Background Weight change during chemotherapy is reported to be associated with a worse prognosis in breast cancer patients, both with weight gain and weight loss. However, most studies were conducted prior to the common use of anthracycline-
Externí odkaz:
https://doaj.org/article/97256f431d89477aaac7e98efecce223
Autor:
Sinsard Anne, D'Incan Michel, Thivat Emilie, Durando Xavier, Madelmont Jean-Claude, Chollet Philippe
Publikováno v:
BMC Cancer, Vol 5, Iss 1, p 147 (2005)
Abstract Background Median survival of metastatic malignant melanoma is 6.0 to 7.5 months, with a 5-year survival of ~6.0%. Although long-term complete remissions are rare, few reports describe cases after chemotherapy. Fifty-three patients with meta
Externí odkaz:
https://doaj.org/article/6adfce9742d9489cba73c8684c382a79
Autor:
Wang-Lopez, Qian, Chalabi, Nassera, Abrial, Catherine, Radosevic-Robin, Nina, Durando, Xavier, Mouret-Reynier, Marie-Ange, Benmammar, Kheir-Eddine, Kullab, Sharif, Bahadoor, Mohun, Chollet, Philippe, Penault-Llorca, Frédérique, Nabholtz, Jean-Marc
Publikováno v:
In Critical Reviews in Oncology / Hematology July 2015 95(1):88-104
Autor:
Iranshahi, Mehrdad, Barthomeuf, Chantal, Bayet-Robert, Mathilde, Chollet, Philippe, Davoodi, Davood, Piacente, Sonia, Rezaee, Ramin, Sahebkar, Amirhossein *
Publikováno v:
In Journal of Traditional and Complementary Medicine April-June 2014 4(2):118-125
Autor:
Cortes, Javier, O'Shaughnessy, Joyce, Loesch, David, Blum, Joanne L, Vahdat, Linda T, Petrakova, Katarina, Chollet, Philippe, Manikas, Alexey, Diéras, Veronique, Delozier, Thierry, Vladimirov, Vladimir, Cardoso, Fatima, Koh, Han, Bougnoux, Philippe, Dutcus, Corina E, Seegobin, Seth, Mir, Denis, Meneses, Nicole, Wanders, Jantien, Twelves, Chris
Publikováno v:
In The Lancet 2011 377(9769):914-923
Publikováno v:
Revue Française de Comptabilité. Jan2022, Issue 560, p41-43. 3p.
Autor:
Innominato, Pasquale F., Karaboué, Abdoulaye, Focan, Christian, Chollet, Philippe, Giacchetti, Sylvie, Bouchahda, Mohamed, Ulusakarya, Ayhan, Torsello, Angela, Adam, René, Lévi, Francis A., Garufi, Carlo
The triplet combination of irinotecan, oxaliplatin and fluorouracil is an active frontline regimen in metastatic colorectal cancer, but scarce data exist on its use as salvage treatment. We aimed at assessing its safety and efficacy profiles with its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::1cd209609d2aa272193f7615625f171a
http://wrap.warwick.ac.uk/145787/1/WRAP-efficacy-safety-chronomodulated-irinotecan-Innominato-2020.pdf
http://wrap.warwick.ac.uk/145787/1/WRAP-efficacy-safety-chronomodulated-irinotecan-Innominato-2020.pdf
Autor:
Passildas, Judith, Passildas‐Jahanmohan, Judith, Eymard, Jean‐Christophe, Pouget, Mélanie, Kwiatkowski, Fabrice, Van Praagh, Isabelle, Savareux, Laurent, Atger, Marc, Durando, Xavier, Abrial, Catherine, Richard, Damien, Ginzac Couvé, Angeline, Thivat, Emilie, Monange, Brigitte, Chollet, Philippe, Mahammedi, Hakim
Publikováno v:
Cancer Medicine
Cancer Medicine, Wiley, 2021, 10 (7), pp.2332-2340. ⟨10.1002/cam4.3806⟩
Cancer Medicine, Vol 10, Iss 7, Pp 2332-2340 (2021)
Cancer Medicine, Wiley, 2021, 10 (7), pp.2332-2340. ⟨10.1002/cam4.3806⟩
Cancer Medicine, Vol 10, Iss 7, Pp 2332-2340 (2021)
Background Metastatic castration‐resistant prostate cancer (mCRPC) patients have a poor prognosis, and curcumin is known to have antineoplastic properties. On the basis of previous phase I and phase II studies, we investigated whether the associati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f910f99bbfae5414dee0e9bb67b5c2
https://hal.archives-ouvertes.fr/hal-03249350
https://hal.archives-ouvertes.fr/hal-03249350
Publikováno v:
In Phytomedicine 2008 15(1):103-111